Elicio Therapeutics to Host Virtual KOL Event on November 11
Elicio Therapeutics says it will host a virtual key opinion leader event on November 11, 2026, focused on ELI-002 7P for metastatic and neoadjuvant PDAC.
Elicio Therapeutics says it will host a virtual key opinion leader event on November 11, 2026, focused on ELI-002 7P for metastatic and neoadjuvant PDAC.